M. Koenig, A. Beggs, M. Moyer, S. Scherpf, K. Heindrich et al., The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion, Am J Hum Genet, vol.45, pp.498-506, 1989.

M. Koenig, E. Hoffman, C. Bertelson, A. Monaco, C. Feener et al., Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell, pp.509-170092, 1987.

S. Kenwrick, M. Patterson, A. Speer, K. Fischbeck, and K. Davies, Molecular analysis of the Duchenne muscular dystrophy region using pulsed field gel electrophoresis, Cell, vol.48, issue.2, pp.351-70092, 1987.
DOI : 10.1016/0092-8674(87)90438-7

K. Flanigan, D. Dunn, A. Von-niederhausern, P. Soltanzadeh, E. Gappmaier et al., Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort, Human Mutation, vol.23, issue.12, pp.1657-66, 2009.
DOI : 10.1002/humu.21114

S. Tuffery-giraud, C. Beroud, F. Leturcq, R. Yaou, D. Hamroun et al., Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase, Human Mutation, vol.23, issue.6, pp.934-979, 2009.
DOI : 10.1002/humu.20976

A. Monaco, C. Bertelson, S. Liechti-gallati, H. Moser, and L. Kunkel, An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus, Genomics, vol.2, issue.1, pp.90-50888, 1988.
DOI : 10.1016/0888-7543(88)90113-9

N. Wein, L. Alfano, and K. Flanigan, Genetics and Emerging Treatments for Duchenne and Becker Muscular Dystrophy, Pediatric Clinics of North America, vol.62, issue.3, pp.723-765, 2015.
DOI : 10.1016/j.pcl.2015.03.008

M. Kohler, C. Clarenbach, L. Boni, T. Brack, E. Russi et al., Quality of Life, Physical Disability, and Respiratory Impairment in Duchenne Muscular Dystrophy, American Journal of Respiratory and Critical Care Medicine, vol.172, issue.8, pp.1032-6200503, 2005.
DOI : 10.1164/rccm.200503-322OC

K. Davies and K. Nowak, Molecular mechanisms of muscular dystrophies: old and new players, Nature Reviews Molecular Cell Biology, vol.103, issue.10, pp.762-73, 2006.
DOI : 10.1038/nrm2024

F. Rahimov and L. Kunkel, Cellular and molecular mechanisms underlying muscular dystrophy, The Journal of Cell Biology, vol.108, issue.4, pp.499-510, 2013.
DOI : 10.1016/S1534-5807(01)00070-3

K. Bushby and D. Gardner-medwin, The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy, Journal of Neurology, vol.120, issue.2, pp.98-104, 1993.
DOI : 10.1007/BF00858725

K. Bushby, D. Gardner-medwin, L. Nicholson, M. Johnson, I. Haggerty et al., The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy, Journal of Neurology, vol.39, issue.2, pp.105-117, 1993.
DOI : 10.1007/BF00858726

B. Petrof, J. Shrager, H. Stedmann, A. Kelly, and H. Sweeney, Dystrophin protects the sarcolemma from stresses developed during muscle contraction., Proceedings of the National Academy of Sciences, vol.90, issue.8, pp.3710-3714, 1993.
DOI : 10.1073/pnas.90.8.3710

M. Neri, S. Torelli, S. Brown, I. Ugo, P. Sabatelli et al., Dystrophin levels as low as 30% are sufficient to avoid muscular dystrophy in the human, Neuromuscular Disorders, vol.17, issue.11-12, pp.913-921, 2007.
DOI : 10.1016/j.nmd.2007.07.005

K. Anthony, S. Cirak, S. Torelli, G. Tasca, L. Feng et al., Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials, Brain, vol.134, issue.12, pp.3544-56, 2011.
DOI : 10.1093/brain/awr291

A. Aartsma-rus, Dystrophin analysis in clinical trials, Journal of Neuromuscular diseases, vol.1, pp.41-53, 2014.

V. Dubowitz and R. Cohn, Dystrophin and Duchenne dystrophy, Neuromuscular Disorders, vol.25, issue.5, pp.361-363
DOI : 10.1016/j.nmd.2015.03.013

J. Ervasti and K. Campbell, Dystrophin and the membrane skeleton, Current Opinion in Cell Biology, vol.5, issue.1, pp.82-89, 1993.
DOI : 10.1016/S0955-0674(05)80012-2

L. Rumeur, E. Winder, S. Hubert, and J. , Dystrophin: More than just the sum of its parts, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, vol.1804, issue.9, pp.1713-1735, 2010.
DOI : 10.1016/j.bbapap.2010.05.001

URL : https://hal.archives-ouvertes.fr/hal-00592430

B. Levine, A. Moir, V. Patchell, and S. Perry, Binding sites involved in the interaction of actin with the N-terminal region of dystrophin, FEBS Letters, vol.173, issue.1, pp.44-80014, 1992.
DOI : 10.1016/0014-5793(92)80019-D

N. Keep, F. Norwood, C. Moores, S. Winder, K. et al., The 2.0?? Structure of the Second Calponin Homology Domain from the Actin-binding Region of the Dystrophin Homologue Utrophin, Journal of Molecular Biology, vol.285, issue.3, pp.1257-64, 1999.
DOI : 10.1006/jmbi.1998.2406

F. Norwood, A. Sutherland-smith, N. Keep, K. , and J. , The structure of the N-terminal actin-binding domain of human dystrophin and how mutations in this domain may cause Duchenne or Becker muscular dystrophy, Structure, vol.8, issue.5, pp.481-91, 2000.
DOI : 10.1016/S0969-2126(00)00132-5

M. Koenig and L. Kunkel, Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility, J Biol Chem, vol.265, pp.4560-4566, 1990.

K. Amann, B. Renley, and J. Ervasti, A Cluster of Basic Repeats in the Dystrophin Rod Domain Binds F-actin through an Electrostatic Interaction, Journal of Biological Chemistry, vol.273, issue.43, pp.28419-28442, 1998.
DOI : 10.1074/jbc.273.43.28419

R. Bhosle, D. Michele, K. Campbell, Z. Li, and R. Robson, Interactions of intermediate filament protein synemin with dystrophin and utrophin, Biochemical and Biophysical Research Communications, vol.346, issue.3, pp.768-77, 2006.
DOI : 10.1016/j.bbrc.2006.05.192

M. Stone, O. Neill, A. Catino, D. Bloch, and R. , Specific Interaction of the Actin-binding Domain of Dystrophin with Intermediate Filaments Containing Keratin 19, Molecular Biology of the Cell, vol.16, issue.9, pp.4280-93, 2005.
DOI : 10.1091/mbc.E05-02-0112

K. Prins, J. Humston, A. Mehta, V. Tate, E. Ralston et al., Dystrophin is a microtubule-associated protein, The Journal of Cell Biology, vol.19, issue.3, pp.363-372, 2009.
DOI : 10.1023/A:1005512217552

J. Belanto, T. Mader, M. Eckhoff, D. Strandjord, G. Banks et al., Microtubule binding distinguishes dystrophin from utrophin, Proceedings of the National Academy of Sciences, vol.111, issue.15, pp.5723-5731, 2014.
DOI : 10.1073/pnas.1323842111

Y. Lai, G. Thomas, Y. Yue, H. Yang, D. Li et al., Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy, Journal of Clinical Investigation, vol.119, issue.3, pp.624-659, 2009.
DOI : 10.1172/JCI36612DS1

Y. Lai, J. Zhao, Y. Yue, and D. Duan, ??2 and ??3 helices of dystrophin R16 and R17 frame a microdomain in the ??1 helix of dystrophin R17 for neuronal NOS binding, Proceedings of the National Academy of Sciences, vol.110, issue.2, pp.525-555, 2013.
DOI : 10.1073/pnas.1211431109

E. Giudice, A. Molza, Y. Laurin, N. A. , L. Rumeur et al., Molecular Clues about the Dystrophin???Neuronal Nitric Oxide Synthase Interaction: A Theoretical Approach, Biochemistry, vol.52, issue.44, pp.7777-84, 2013.
DOI : 10.1021/bi400794p

URL : https://hal.archives-ouvertes.fr/hal-00935150

K. Yamashita, A. Suzuki, Y. Satoh, M. Ide, Y. Amano et al., The 8th and 9th tandem spectrin-like repeats of utrophin cooperatively form a functional unit to interact with polarity-regulating kinase PAR-1b, Biochemical and Biophysical Research Communications, vol.391, issue.1, pp.812-819, 2010.
DOI : 10.1016/j.bbrc.2009.11.144

L. Rumeur, E. Fichou, Y. Pottier, S. Gaboriau, F. Rondeau-mouro et al., Interaction of Dystrophin Rod Domain with Membrane Phospholipids: EVIDENCE OF A CLOSE PROXIMITY BETWEEN TRYPTOPHAN RESIDUES AND LIPIDS, Journal of Biological Chemistry, vol.278, issue.8, pp.5993-6001, 2003.
DOI : 10.1074/jbc.M207321200

S. Legardinier, J. Hubert, L. Bihan, O. Tascon, C. Rocher et al., Sub-domains of the dystrophin rod domain display contrasting lipid-binding and stability properties, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, vol.1784, issue.4, pp.672-82, 2008.
DOI : 10.1016/j.bbapap.2007.12.014

URL : https://hal.archives-ouvertes.fr/hal-00457831

S. Legardinier, C. Raguénès-nicol, C. Tascon, C. Rocher, S. Hardy et al., Mapping of the Lipid-Binding and Stability Properties of the Central Rod Domain of Human Dystrophin, Journal of Molecular Biology, vol.389, issue.3, pp.546-58, 2009.
DOI : 10.1016/j.jmb.2009.04.025

URL : https://hal.archives-ouvertes.fr/inserm-00404317

K. Campbell and S. Kahl, Association of dystrophin and an integral membrane glycoprotein, Nature, vol.338, issue.6212, pp.259-62, 1989.
DOI : 10.1038/338259a0

J. Ervasti and K. Campbell, A Role for the Dystrophin-Glycoprotein Complex as aTransmembrane Linker between Laminin and Actin

X. Huang, F. Poy, R. Zhang, A. Joachimiak, M. Sudol et al., Structure of a WW domain containing fragment of dystrophin in complex with beta-dystroglycan, Nature Structural Biology, vol.7, issue.8, pp.634-642, 2000.
DOI : 10.1038/77923

K. Hnia, D. Zouiten, S. Cantel, D. Chazalette, G. Hugon et al., ZZ domain of dystrophin and utrophin: topology and mapping of a ??-dystroglycan interaction site, Biochemical Journal, vol.401, issue.3, pp.667-77, 2007.
DOI : 10.1042/BJ20061051

URL : https://hal.archives-ouvertes.fr/inserm-00144563

G. Rezniczek, P. Konieczny, B. Nikolic, S. Reipert, D. Schneller et al., ) muscle fibers through multiple interactions with ??-dystroglycan, The Journal of Cell Biology, vol.113, issue.7, pp.965-77, 2007.
DOI : 10.1242/jcs.00911

G. Ayalon, J. Davis, P. Scotland, V. Bennett, H. Sadoulet-puccio et al., An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan . Cell Dystrobrevin and dystrophin: An interaction through coiled-coil motifs, Proc Natl Acad Sci USA, vol.13594, pp.1189-20012413, 1997.

S. Newey, M. Benson, C. Ponting, K. Davies, and D. Blake, Alternative splicing of dystrobrevin regulates the stoichiometry of syntrophin binding to the dystrophin protein complex, Current Biology, vol.10, issue.20
DOI : 10.1016/S0960-9822(00)00760-0

E. Zubrzycka-gaarn, D. Bulman, G. Karpati, A. Burghes, B. Belfall et al., The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle, Nature, vol.333, issue.6172, pp.466-475, 1988.
DOI : 10.1038/333466a0

O. Jaka, L. Casas-fraile, A. Lopez-de-munain, and A. Saenz, Costamere proteins and their involvement in myopathic processes, Expert Reviews in Molecular Medicine, vol.278, p.12, 2015.
DOI : 10.1073/pnas.81.11.3292

J. Ervasti, Costameres: the Achilles' Heel of Herculean Muscle, Journal of Biological Chemistry, vol.278, issue.16, pp.13591-13595, 2003.
DOI : 10.1074/jbc.R200021200

R. Bloch, Y. Capetanaki, O. Neill, A. Reed, P. Williams et al., Costameres: Repeating Structures at the Sarcolemma of Skeletal Muscle, Clinical Orthopaedics and Related Research, vol.403, pp.203-1000003086, 2002.
DOI : 10.1097/00003086-200210001-00024

R. Bloch and H. Gonzalez-serratos, Lateral Force Transmission Across Costameres in Skeletal Muscle, Exercise and Sport Sciences Reviews, vol.31, issue.2, pp.73-81, 2003.
DOI : 10.1097/00003677-200304000-00004

A. Kumar, N. Khandelwal, R. Malya, M. Reid, and A. Boriek, Loss of dystrophin causes aberrant mechanotransduction in skeletal muscle fibers, The FASEB Journal, vol.18, issue.1, pp.102-115, 2004.
DOI : 10.1096/fj.03-0453com

R. Bloch, P. Reed, O. Neill, A. Strong, J. Williams et al., Costameres mediate force transduction in healthy skeletal muscle and are altered in muscular dystrophies, J Muscle Res Cell Motil, vol.25, pp.590-592, 2004.

R. Bloch, P. Reed, O. Neill, A. Strong, J. Williams et al., Costameres mediate force transduction in healthy skeletal muscle and are altered in muscular dystrophies, J Muscle Res Cell Motil, vol.25, pp.590-592, 2004.

M. Mariol and L. Segalat, Muscular degeneration in the absence of dystrophin is a calcium-dependent process, Current Biology, vol.11, issue.21
DOI : 10.1016/S0960-9822(01)00528-0

S. Harper, M. Hauser, C. Dellorusso, D. Duan, R. Crawford et al., Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy, Nature Medicine, vol.8, issue.3, pp.253-61, 2002.
DOI : 10.1038/nm0302-253

S. England, L. Nicholson, M. Johnson, S. Forrest, D. Love et al., Very mild muscular dystrophy associated with the deletion of 46% of dystrophin, Nature, vol.343, issue.6254, pp.180-182, 1990.
DOI : 10.1038/343180a0

J. Seto, J. Ramos, L. Muir, J. Chamberlain, and G. Odom, Gene Replacement Therapies for Duchenne Muscular Dystrophy Using Adeno-Associated Viral Vectors, Current Gene Therapy, vol.12, issue.3, pp.139-51
DOI : 10.2174/156652312800840603

R. Fairclough, M. Wood, and K. Davies, Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches, Nature Reviews Genetics, vol.867, issue.6, pp.373-381
DOI : 10.1002/jgm.1288

S. Jarmin, H. Kymalainen, L. Popplewell, and G. Dickson, New developments in the use of gene therapy to treat Duchenne muscular dystrophy, Expert Opinion on Biological Therapy, vol.60, issue.5, pp.209-239, 2014.
DOI : 10.1002/humu.20918

J. Mcgreevy, C. Hakim, M. Mcintosh, and D. Duan, Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy, Disease Models & Mechanisms, vol.8, issue.3, pp.195-213
DOI : 10.1242/dmm.018424

P. Gregorevic, M. Blankinship, J. Allen, and J. Chamberlain, Systemic Microdystrophin Gene Delivery Improves Skeletal Muscle Structure and Function in Old Dystrophic mdx Mice, Molecular Therapy, vol.16, issue.4, pp.657-64, 2008.
DOI : 10.1038/mt.2008.28

H. Foster, P. Sharp, T. Athanasopoulos, C. Trollet, I. Graham et al., Codon and mRNA Sequence Optimization of Microdystrophin Transgenes Improves Expression and Physiological Outcome in Dystrophic mdx Mice Following AAV2/8 Gene Transfer, Molecular Therapy, vol.16, issue.11, pp.1825-1857, 2008.
DOI : 10.1038/mt.2008.186

A. Goyenvalle, A. Vulin, F. Fougerousse, F. Leturcq, J. Kaplan et al., Rescue of dystrophic muscle through U7 snR- NA-mediated exon skipping, Science, vol.306, 2004.

A. Aartsma-rus, A. Janson, J. Heemskerk, D. Winter, C. Van-ommen et al., Therapeutic Modulation of DMD Splicing by Blocking Exonic Splicing Enhancer Sites with Antisense Oligonucleotides, Annals of the New York Academy of Sciences, vol.108, issue.1, pp.74-80, 2006.
DOI : 10.1089/oli.2005.15.284

A. Aartsma-rus, A. Janson, W. Kaman, M. Bremmer-bout, G. Van-ommen et al., Antisense-Induced Multiexon Skipping for Duchenne Muscular Dystrophy Makes More Sense, The American Journal of Human Genetics, vol.74, issue.1, pp.83-92
DOI : 10.1086/381039

Y. Takeshima, M. Yagi, H. Wada, K. Ishibashi, A. Nishiyama et al., Intravenous Infusion of an Antisense Oligonucleotide Results in Exon Skipping in Muscle Dystrophin mRNA of Duchenne Muscular Dystrophy, Pediatric Research, vol.8, issue.5, pp.690-694, 2006.
DOI : 10.1203/01.pdr.0000215047.51278.7c

G. Mcclorey, H. Moulton, P. Iversen, S. Fletcher, and S. Wilton, Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD, Gene Therapy, vol.4, issue.19, pp.1373-81, 2006.
DOI : 10.1038/sj.gt.3302800

A. Vulin, I. Barthelemy, A. Goyenvalle, J. Thibaud, C. Beley et al., Muscle Function Recovery in Golden Retriever Muscular Dystrophy After AAV1-U7 Exon Skipping, Molecular Therapy, vol.20, issue.11, pp.2120-2153, 2012.
DOI : 10.1038/mt.2012.181

A. Aartsma-rus and F. Muntoni, 194th ENMC international workshop. 3rd ENMC workshop on exon skipping: Towards clinical application of antisense-mediated exon skipping for Duchenne muscular dystrophy 8???10 December 2012, Naarden, The Netherlands, Neuromuscular Disorders, vol.23, issue.11, pp.934-978, 2012.
DOI : 10.1016/j.nmd.2013.06.369

L. Guiner, C. Montus, M. Servais, L. Cherel, Y. Francois et al., Forelimb Treatment in a Large Cohort of Dystrophic Dogs Supports Delivery of a Recombinant AAV for Exon Skipping in Duchenne Patients, Molecular Therapy, vol.22, issue.11, pp.1923-1958
DOI : 10.1038/mt.2014.151

J. Van-deutekom, A. Janson, I. Ginjaar, W. Frankhuizen, A. Aartsma-rus et al., Local Dystrophin Restoration with Antisense Oligonucleotide PRO051, New England Journal of Medicine, vol.357, issue.26, pp.2677-86, 2007.
DOI : 10.1056/NEJMoa073108

M. Kinali, V. Arechavala-gomeza, L. Feng, S. Cirak, D. Hunt et al., Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study, The Lancet Neurology, vol.8, issue.10, pp.918-946, 2009.
DOI : 10.1016/S1474-4422(09)70211-X

N. Goemans, M. Tulinius, J. Van-den-akker, B. Burm, P. Ekhart et al., Systemic administration of PRO051 in Duchenne' s muscular dystrophy Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study, N Engl J Med Lancet, vol.364378, issue.11, pp.1513-22595, 2011.

S. Cirak, L. Feng, K. Anthony, V. Arechavala-gomeza, S. Torelli et al., Restoration of the Dystrophin-associated Glycoprotein Complex After Exon Skipping Therapy in Duchenne Muscular Dystrophy, Molecular Therapy, vol.20, issue.2, 2011.
DOI : 10.1038/mt.2011.248

S. Guiraud, A. Aartsma-rus, N. Vieira, K. Davies, G. Van-ommen et al., The Pathogenesis and Therapy of Muscular Dystrophies, Annual Review of Genomics and Human Genetics, vol.16, issue.1, 2015.
DOI : 10.1146/annurev-genom-090314-025003

S. Wilton, R. Veedu, and S. Fletcher, The emperor' s new dystrophin: finding sense in the noise, Trends Mol Med, 2015.

A. Findlay, N. Wein, Y. Kaminoh, L. Taylor, D. Dunn et al., exon 45, Annals of Neurology, vol.1794, issue.pt 3, pp.668-74, 2015.
DOI : 10.1002/ana.24365

URL : https://hal.archives-ouvertes.fr/hal-01117017

A. Nicolas, C. Raguenes-nicol, B. Yaou, R. , A. Hir et al., Becker muscular dystrophy severity is linked to the structure of dystrophin, Human Molecular Genetics, vol.24, issue.5, pp.1267-79, 2015.
DOI : 10.1093/hmg/ddu537

URL : https://hal.archives-ouvertes.fr/hal-01117005

D. Cacchiarelli, J. Martone, E. Girardi, M. Cesana, T. Incitti et al., MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway. Cell Metab, pp.341-51, 2010.

D. Cacchiarelli, T. Incitti, J. Martone, M. Cesana, V. Cazzella et al., miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy, EMBO reports, vol.119, issue.2, pp.136-177, 2011.
DOI : 10.1161/CIRCRESAHA.108.183426

URL : https://hal.archives-ouvertes.fr/pasteur-00976757

B. Kerst, D. Mennerich, M. Schuelke, G. Stoltenburg-didinger, A. Von-moers et al., Heterozygous myogenic factor 6 mutation associated with myopathy and severe course of Becker muscular dystrophy, Neuromuscular Disorders, vol.10, issue.8, pp.572-579, 2000.
DOI : 10.1016/S0960-8966(00)00150-4

D. Davis, A. Delmonte, C. Ly, and E. Mcnally, Myoferlin, a candidate gene and potential modifier of muscular dystrophy, Human Molecular Genetics, vol.9, issue.2, pp.217-243, 2000.
DOI : 10.1093/hmg/9.2.217

E. Pegoraro, E. Hoffman, L. Piva, B. Gavassini, S. Cagnin et al., SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy, Neurology, vol.76, issue.3, pp.219-245, 2011.
DOI : 10.1212/WNL.0b013e318207afeb

L. Bello, L. Piva, A. Barp, A. Taglia, E. Picillo et al., Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy, Neurology, vol.79, issue.2, pp.159-62, 2012.
DOI : 10.1212/WNL.0b013e31825f04ea

K. Flanigan, E. Ceco, K. Lamar, Y. Kaminoh, D. Dunn et al., LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy, Ann Neurol. 2013, vol.73, pp.481-489